Press Releases

The Assistance Fund Opens New Program for Cold Agglutinin Disease

FOR IMMEDIATE RELEASE

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Cold Agglutinin Disease

ORLANDO, Fla., February 21, 2022 —The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new financial assistance program for people living with cold agglutinin disease. The program is designed to help eligible individuals pay for their out-of-pocket medical costs for FDA-approved treatment such as prescription drug copayments, health insurance premiums, and incidental medical expenses.

People living with cold agglutinin disease—a rare, autoimmune disease—are triggered by cold, winter weather. In those temperatures, proteins in the blood bind themselves to red blood cells. This process can lead to anemia. Many individuals living with cold agglutinin disease experience joint pain, fatigue, dizziness, and muscle weakness.¹

“Removing financial worry is critical for improving the quality of life for people diagnosed with cold agglutinin disease,” said Mark P. McGreevy, President and CEO of The Assistance Fund. “Thanks to the strong commitment of our donors our Cold Agglutinin Disease Financial Assistance Program is now open, ensuring more patients can get the care they need.”

To learn more or determine eligibility for financial support, visit tafcares.org or call (833) 519-0408 to speak with a Patient Advocate.

A list of all the disease programs available from The Assistance Fund can be found on the website tafcares.org.

About The Assistance Fund

The Assistance Fund (TAF) is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. The Assistance Fund currently manages more than 70 disease programs, each of which covers the FDA-approved medications that treat a specific disease. Since its founding in 2009, TAF has helped more than 160,000 children and adults access the treatment they need to stay healthy or manage a life-threatening, chronic, or rare disease. To learn more about The Assistance Fund, or for information on how to donate, please visit tafcares.org.

Media Contact
Margaret Figley
Senior Director of Communications
margaret.figley@tafcares.org


¹”Cold agglutinin disease.” NCATS. National Institutes of Health. (February 9, 2022). Retrieved from: https://rarediseases.info.nih.gov/diseases/6130/cold-agglutinin-disease.

Share This
Categories: Press Releases
Close Menu-Close

Need Help Finding Something?

Explore our site